KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Profit After Tax: 2010-2024

Historic Profit After Tax for TherapeuticsMD (TXMD) over the last 15 years, with Dec 2024 value amounting to -$2.3 million.

  • TherapeuticsMD's Profit After Tax rose 124.96% to $152,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $171,000, marking a year-over-year increase of 105.04%. This contributed to the annual value of -$2.3 million for FY2024, which is 77.51% up from last year.
  • As of FY2024, TherapeuticsMD's Profit After Tax stood at -$2.3 million, which was up 77.51% from -$10.3 million recorded in FY2023.
  • In the past 5 years, TherapeuticsMD's Profit After Tax registered a high of $112.0 million during FY2022, and its lowest value of -$183.5 million during FY2020.
  • Moreover, its 3-year median value for Profit After Tax was -$2.3 million (2024), whereas its average is $33.1 million.
  • In the last 5 years, TherapeuticsMD's Profit After Tax surged by 164.96% in 2022 and then slumped by 109.18% in 2023.
  • Yearly analysis of 5 years shows TherapeuticsMD's Profit After Tax stood at -$183.5 million in 2020, then rose by 6.05% to -$172.4 million in 2021, then spiked by 164.96% to $112.0 million in 2022, then crashed by 109.18% to -$10.3 million in 2023, then skyrocketed by 77.51% to -$2.3 million in 2024.